Venue: The Peninsula Paris
Time: 9:00 - 16:00
France Biotech, with the help of the European health innovation ecosystem, is organizing a HealthTech Investor Day in Paris (Peninsula Palace), on June 24th & 25th – www.htid-paris.com, under the high patronage of the French President. This international event has our support as well as of several European partners such as the European Biopharmaceutical Enterprises and Euronext.
This European business event aims to connect leading investors (European, American and Asian), pharmaceuticals companies and C-level executives from European innovative companies in HealthTech (biotech, medtech and e-health).
This event will bring together private and listed healthtech companies (biotech, medtech, e-health) willing to address leading investors and pharmaceutical companies.
This event includes:
This event is pan-European with the presence of several prestigious speakers for panel discussions and key pharma players present such as Sanofi, Ipsen, Boehringer-Ingelheim, Amgen as well as leading American, Asian and European investors such as KKR and OrbiMed to name a few (currently registered companies and investors visible on the website www.htid-paris.com).
EuropaBio supports this event and will participate in one of the panel discussions on the attractiveness of Europe in health innovation.
This will be a great opportunity for DANISH BIO – DANSK BIOTEK’s members to meet biotech, medtech companies, investors and pharma as well as key political and industry stakeholders all in one place.
Biotech and medtech companies can register via the following link:
A special discount will be offered to biotech, medtech and e-health companies which are members of DANISH BIO – DANSK BIOTEK.
Large pharmaceutical companies and investors can also register via the following link by completing the registration form in “Application form for international Life Sciences community”: